Sort
15,273 grants matching “antimicrobial resistance”
Characterizing the role of antimicrobial peptide resistance in plague transmission
$380,834Mark A Fisher · University Of Utah · R01 · FY2018 · AI
Bacterial Surface Structures of Helicobacter Pylori and Campylobacter Jejuni
$380,787Michael Stephen Trent · University Of Texas At Austin · R01 · FY2014 · AI
Vaccine Assembly from Surface Proteins of Staphylococcus Aureus
$380,778Olaf Schneewind · University Of Chicago · R01 · FY2010 · AI
The role of CshA and CshB in selective mRNA protection in S. aureus
$380,504Ambrose L. Cheung · Dartmouth College · R01 · FY2013 · AI
Chemical Biology of Infectious Diseases (CBID) Training Program
$380,478Eric P Skaar · Vanderbilt University · T32 · FY2021 · AI
Molecular Mechanisms Underlying Fluoroquinolone Susceptibility and Resistance
$380,400Elizabeth Lynn Zechiedrich · Baylor College Of Medicine · R01 · FY2015 · GM
Molecular Mechanisms Underlying Fluoroquinolone Susceptibility and Resistance
$380,400Elizabeth Lynn Zechiedrich · Baylor College Of Medicine · R01 · FY2017 · GM
Molecular Mechanisms Underlying Fluoroquinolone Susceptibility and Resistance
$380,400Elizabeth Lynn Zechiedrich · Baylor College Of Medicine · R01 · FY2016 · GM
Genomic approaches of discovery broad-spectrum antimicrobial agents
$380,360Jon Clardy · Harvard Medical School · U54 · FY2010 · AI
Biogenesis and Function of Streptococcus Pyogenes Cell Wall
$380,280Natalia Korotkova · University Of Kentucky · R01 · FY2022 · AI
O2-Dependent Host Defenses in Resistance to Burkholdria
$380,271Andres Vazquez-Torres · Colorado State University · U54 · FY2007 · AI
Gonococci: Genetics of Resistance to PMN Proteins
$380,267William Maurice Shafer · Emory University · R37 · FY2011 · AI
The Role of ESCRT in Macrophage Resistance to Mycobacteria
$380,250Jennifer A Philips · New York University School Of Medicine · R01 · FY2011 · AI
Virulence mechanisms of group A streptococcal toxins
$380,250Michael R Wessels · Boston Children'S Hospital · R01 · FY2008 · AI
Host-pathogen signaling in group A streptococcal infection
$380,250Michael R Wessels · Boston Children'S Hospital · R01 · FY2008 · AI
SET Domain Epigenetic Factors Govern Antifungal Drug Efficacy and Fungal Pathogenesis
$380,246Scott D Briggs · Purdue University · R01 · FY2020 · AI
SET Domain Epigenetic Factors Govern Antifungal Drug Efficacy and Fungal Pathogenesis
$380,246Scott D Briggs · Purdue University · R01 · FY2022 · AI
SET Domain Epigenetic Factors Govern Antifungal Drug Efficacy and Fungal Pathogenesis
$380,246Scott D Briggs · Purdue University · R01 · FY2021 · AI
SET Domain Epigenetic Factors Govern Antifungal Drug Efficacy and Fungal Pathogenesis
$380,246Scott D Briggs · Purdue University · R01 · FY2019 · AI
A Meningococcal LOS Vaccine
$380,138John McLeod Griffiss · Northern California Institute/Res/Edu · R01 · FY2009 · AI
A Meningococcal LOS Vaccine
$380,138John McLeod Griffiss · Northern California Institute/Res/Edu · R01 · FY2008 · AI
Quinolone Resistance Mechanisms in Staphylococcus aureus
$380,103David C Hooper · Massachusetts General Hospital · R01 · FY2006 · AI
Bacterial and host factors in pneumococcal competition
$380,011Jeffrey N. Weiser · University Of Pennsylvania · R01 · FY2012 · AI
Bacterial and host factors in pneumococcal competition
$380,011Jeffrey N. Weiser · University Of Pennsylvania · R01 · FY2011 · AI
Treatment of microbial keratitis and corneal wound healing
$380,007Manav Mehta · Gel4med, Inc. · R43 · FY2020 · EY